Molecules Drugs And Research Laboratory Private Limited, a active private limited company, was established on 16 January 2009 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100TN2009PTC070500. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.
It upholds a compliant status. Its leadership includes Ganesan Sureshpandian (Director), Asaraf Ali (Director), Durai Samy Murugesan (Director). Past directors included Murugesan Sudha, Kumaran, Asaraf Ali. It holds ₹9.53 M open charges and ₹1.20 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.1, V.O.C. Second Main Road Kodambakkam, Chennai, Tamil Nadu, 600024.
U24100TN2009PTC070500
070500
16 January 2009
₹2.00 Cr
₹2.00 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Molecules Drugs And Research Laboratory Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ganesan Sureshpandian | Director | 17 Nov 2009 | Current |
| Asaraf Ali | Director | 17 Nov 2009 | Current |
| Durai Samy Murugesan | Director | 16 Jan 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Dec 2018 | Past |
| Pramod Abcsdd | Director | 11 Dec 2018 | Past |
| Pramod Abcsdd | Director | 29 Aug 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Molecules Drugs And Research Laboratory Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 291.61% decrease in profit. The company's net worth dipped by a decrease of 3.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Molecules Drugs And Research Laboratory had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹9,525,000.00
₹12,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2010 | Indian Bank | ₹9.53 M | Open |
| 28 Jan 2016 | Indian Bank | ₹1.20 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Molecules Drugs And Research Laboratory, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Molecules Drugs And Research Laboratory, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Molecules Drugs And Research Laboratory's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Molecules Drugs And Research Laboratory Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Molecules Drugs And Research Laboratory Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
The activity A charge registered on 28 Jan 2016 via Charge ID 10616792 with Indian Bank was fully satisfied on 18 May 2016. was completed.
The activity A charge with Indian Bank amounted to Rs. 1.20 Cr with Charge ID 10616792 was registered on 28 Jan 2016. was completed.
Progress on A charge with Indian Bank amounted to Rs. 0.95 Cr with Charge ID 10217246 was registered on 30 Mar 2010. was documented.
The activity Ganesan Sureshpandian was appointed as a Director was appointed as a Director on 17 Nov 2009 & has been associated with this company since 16 years 10 days . was completed.
The CIN of Molecules Drugs And Research Laboratory Private Limited is U24100TN2009PTC070500.
Molecules Drugs And Research Laboratory Private Limited is headquartered at No.1, V.O.C. Second Main Road Kodambakkam, Chennai, Tamil Nadu, 600024.
Molecules Drugs And Research Laboratory Private Limited was incorporated on 16 January 2009.
The current directors of Molecules Drugs And Research Laboratory Private Limited are
The primary industry of Molecules Drugs And Research Laboratory Private Limited is Manufacturing.
Molecules Drugs And Research Laboratory Private Limited is unlisted.
The authorized capital of Molecules Drugs And Research Laboratory Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.
The compliance status of Molecules Drugs And Research Laboratory Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX